Clinical Drug Experience Knowledgebase

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (4 trials)

covax (2 trials)

covax-19 (2 trials)

dtap (2 trials)

inactivated influenza vaccine (4 trials)

ipv (1 trial)

live oral poliovirus type 1, 2 and 3 (1 trial)

mmr (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

sipv (1 trial)

tivantinib (1 trial)

11-valent recombinant human papilloma virus vaccine (2 trials)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)